A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
Clinical trial NCT04124965 · COMPLETED
Trial details
- NCT number
- NCT04124965
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-29
- Primary completion
- 2021-09-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.